Oliver Lagore Vanvalin Investment Group Cassava Sciences Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Cassava Sciences Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 1,100 shares of SAVA stock, worth $3,113. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,100
Previous 1,025
7.32%
Holding current value
$3,113
Previous $12,000
166.67%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
205Shares Held
13.9MCall Options Held
2.98MPut Options Held
6.57M-
Black Rock Inc. New York, NY3.22MShares$9.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$7.14 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$3.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.85 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO580KShares$1.64 Million7.83% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $113M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...